000 | 01255 a2200349 4500 | ||
---|---|---|---|
005 | 20250517054352.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.5460 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYin, Weijiao | |
245 | 0 | 0 |
_aEfficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials. _h[electronic resource] |
260 |
_bOncotarget _cNov 2015 |
||
300 |
_a39365-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis | ||
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCapecitabine _xadverse effects |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPei, Guangsheng | |
700 | 1 | _aLiu, Gang | |
700 | 1 | _aHuang, Li | |
700 | 1 | _aGao, Shegan | |
700 | 1 | _aFeng, Xiaoshan | |
773 | 0 |
_tOncotarget _gvol. 6 _gno. 36 _gp. 39365-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.5460 _zAvailable from publisher's website |
999 |
_c25309645 _d25309645 |